Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. Emgality
Emgality Image

Emgality

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Emgality?

Emgality is a prescription medication that has been approved by the FDA for the prevention of migraines in adults. Additionally, it can also be used to treat specific types of headaches known as episodic cluster headaches in adults. The active ingredient in Emgality is galcanezumab, which belongs to a class of drugs called calcitonin gene-related peptide (CGRP) inhibitors. CGRP is a protein that is involved in the transmission of pain signals in the brain, and by inhibiting CGRP, Emgality helps to reduce the frequency and severity of migraines and cluster headaches. Emgality is administered as a subcutaneous injection, which means it is injected under the skin, typically once a month. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. As with any medication, Emgality may cause side effects. Common side effects include injection site reactions such as pain, redness, and itching. Other potential side effects may include allergic reactions, constipation, and fatigue. It is advised to discuss any concerns or questions with your healthcare provider before starting treatment with Emgality.

How to use Emgality?

To use Emgality, follow the instructions provided by your healthcare professional. Generally, Emgality comes in a prefilled syringe or autoinjector device for subcutaneous injection, which means it is injected just below the skin. Here are some general steps on how to use Emgality: 1. Before injecting Emgality, make sure to wash your hands thoroughly. 2. Choose an injection site, typically on your abdomen, thigh, or upper arm. Rotate the injection site with each dose to prevent irritation or lumps. 3. Clean the chosen injection site with an alcohol wipe and let it dry. 4. Remove the cap from the Emgality prefilled syringe or autoinjector. 5. Pinch the cleaned skin around the injection site to create a small fold. 6. Hold the Emgality syringe or autoinjector like a pencil or pen and firmly press it against the skin at a 45-degree angle. 7. Press the plunger slowly but firmly to inject the medication beneath the skin. 8. Once the injection is complete, remove the syringe or autoinjector from the skin. 9. Gently apply pressure on the injection site with a clean cotton ball or gauze pad. 10. Dispose of the used syringe or autoinjector properly in a sharps container. Always refer to the specific instructions provided by your healthcare professional or read the medication guide that accompanies Emgality for detailed usage guidelines. If you have any concerns or questions regarding the administration of Emgality, consult your doctor or pharmacist for further guidance.

When it comes to the use of Emgality, there are several important warnings to be aware of. Firstly, it is crucial to inform your healthcare provider about any known allergies to galcanezumab or any other ingredients contained in the medication. Additionally, Emgality may cause an allergic reaction, which could be severe. Symptoms of an allergic reaction include difficulty breathing, rash, itching, swelling of the face, lips, tongue, or throat. If these symptoms occur, seeking immediate medical attention is necessary. It's important to note that Emgality is not intended for the treatment of acute migraines or cluster headaches. This medication is specifically formulated for preventive purposes and should be used as prescribed by a healthcare professional. There have been reports of increased risk of depression and suicidal thoughts or behaviors in patients taking Emgality. It's crucial to monitor for any changes in mood, behavior, or worsening of depression while using this medication. As with any prescription drug, there may be interactions with other medications. It's essential to inform your doctor of all the medications, supplements, and herbal products you are currently taking to ensure there are no potential interactions. Lastly, as with any medication, Emgality may cause side effects. Common side effects include injection site reactions, such as pain, redness, or swelling, and constipation. If you experience any severe or persistent side effects, it's important to contact your healthcare provider for further guidance. Remember to always follow the prescribed dosage and instructions provided by your doctor or healthcare professional.

Before taking Emgality, it is important to be aware of certain warnings and precautions associated with the medication. Here is some essential information to keep in mind: 1. Allergy: Individuals with a known allergy or hypersensitivity to galcanezumab-gnlm, the active ingredient in Emgality, should not take this medication. 2. Infections: Emgality may increase the risk of developing infections, including upper respiratory tract infections. It is essential to inform your healthcare provider if you have any existing infections or if you develop symptoms such as fever or flu-like symptoms during treatment. 3. Hypersensitivity reactions: Serious allergic reactions, such as anaphylaxis, have been reported with Emgality. Seek immediate medical attention if you experience any signs of an allergic reaction, such as rash, itching, difficulty breathing, or swelling of the face, lips, tongue, or throat. 4. Liver problems: Emgality may affect liver function. Inform your healthcare provider about any history of liver disease or if you experience symptoms such as jaundice (yellowing of the skin or eyes), dark urine, or persistent abdominal pain. 5. Pregnancy and breastfeeding: The safety of Emgality during pregnancy and breastfeeding is not well-established. It is essential to discuss the risks and benefits with your healthcare provider before using this medication if you are pregnant or breastfeeding. 6. Other medications: Inform your healthcare provider about all the medications, supplements, and herbal products you are taking, as certain medications may interact with Emgality. This includes both prescription and over-the-counter drugs. 7. Adverse effects: Like any medication, Emgality can cause side effects. The most common side effects reported in clinical trials include injection site reactions (pain, redness, swelling), itching, and hypersensitivity reactions. It is advisable to speak with your healthcare provider about what to expect and how to manage any potential side effects. Remember, these warnings and precautions are not exhaustive, and it is important to consult your healthcare provider or read the full prescribing information for Emgality for a comprehensive understanding of its potential risks and benefits tailored to your specific situation.

Emgality, also known by its generic name galcanezumab, is a prescription drug that is approved by the FDA for the preventive treatment of migraines in adults. It can also be used to treat episodic cluster headaches in adults. Like any medication, Emgality can cause side effects in some individuals. The most common side effects reported with Emgality include injection site reactions, such as pain, redness, or itching at the injection site. Other potential side effects may include allergic reactions, such as rash, itching, or difficulty breathing. It is essential to be aware that while these side effects are possible, not everyone who takes Emgality will experience them. It is always recommended to discuss any concerns or potential side effects with a healthcare provider before starting any new medication. They can provide individualized guidance and monitor your progress to ensure the best possible outcomes.

The active ingredient in Emgality is galcanezumab-gnlm. Emgality is a monoclonal antibody that specifically targets a protein called calcitonin gene-related peptide (CGRP), which is involved in the development of migraines and cluster headaches. By blocking CGRP, Emgality helps to prevent the onset of migraines and lessen their frequency and intensity. In addition to the active ingredient, Emgality also contains other inactive ingredients that help to formulate the medication into an injectable solution. These ingredients include citric acid monohydrate, sodium citrate dihydrate, histidine, polysorbate 80, and water for injection. It's worth noting that Emgality is a prescription medication and should only be used under the guidance and supervision of a healthcare professional. As with any medication, it's important to discuss potential side effects, risks, and benefits with your doctor before starting treatment.

When it comes to storing Emgality, there are a few guidelines to follow to ensure the medication remains effective and safe for use. It is important to keep Emgality refrigerated between 36°F to 46°F (2°C to 8°C). However, the medication can be stored at room temperature, not exceeding 77°F (25°C), for a maximum of 7 days. If you need to transport Emgality, it can be kept at a temperature not exceeding 77°F (25°C) for up to 7 days. However, if it is exposed to temperatures exceeding 77°F (25°C), it must be discarded. It is crucial to remember that Emgality should be kept in its original carton to protect it from light. Do not freeze the medication, as it can render it ineffective. Additionally, make sure to keep Emgality out of the reach of children and pets. If you have any concerns or questions about how to store Emgality, it is best to consult your healthcare provider or pharmacist, who can provide further guidance and answer any specific queries you may have.